These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6302938)

  • 1. Use of interferon in cytomegalovirus infections in man.
    Hirsch MS
    Tex Rep Biol Med; 1981-1982; 41():566-70. PubMed ID: 6302938
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic approaches to the control of cytomegalovirus infections.
    Dworsky M; Pass RF; Stagno S; Whitley RJ
    Birth Defects Orig Artic Ser; 1984; 20(1):345-52. PubMed ID: 6329371
    [No Abstract]   [Full Text] [Related]  

  • 3. Human interferon as a therapeutic agent--current status.
    Merigan TC
    N Engl J Med; 1983 Jun; 308(25):1530-1. PubMed ID: 6190083
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prophylactic and therapeutic treatment of cytomegalovirus infections in kidney transplant recipients].
    Takahashi K; Ebihara K; Ota K
    Nihon Rinsho; 1989 Feb; 47(2):459-65. PubMed ID: 2542668
    [No Abstract]   [Full Text] [Related]  

  • 5. The incidence of cytomegalo- and herpes simplex virus infections in renal allograft recipients treated with high dose recombinant leucocyte interferon: a controlled study.
    Weimar W; Kramer P; Bijnen AB; Jeekel J; Rothbarth PH; Masurel N
    Scand J Urol Nephrol Suppl; 1985; 92():37-9. PubMed ID: 3008315
    [No Abstract]   [Full Text] [Related]  

  • 6. Human cytomegalovirus-associated pneumonitis: pathogenesis, prevention, and treatment.
    Zaia JA; Kovacs A; Forman SJ
    Transplant Proc; 1987 Dec; 19(6 Suppl 7):125-31. PubMed ID: 2827357
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of interferon in herpes simplex infections in man.
    Armstrong JA
    Tex Rep Biol Med; 1981-1982; 41():571-4. PubMed ID: 6189222
    [No Abstract]   [Full Text] [Related]  

  • 8. Foscarnet prophylaxis in marrow transplant recipients.
    Ringden O; Lonnqvist B; Aschan J; Sundberg B
    Bone Marrow Transplant; 1989 Nov; 4(6):713. PubMed ID: 2555006
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of hyperimmune anti-cytomegalovirus immunoglobulins for the prevention of cytomegalovirus infection in recipients of allogeneic bone marrow transplantation: a meta-analysis.
    Messori A; Rampazzo R; Scroccaro G; Martini N
    Bone Marrow Transplant; 1994 Feb; 13(2):163-7. PubMed ID: 8205085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous lymphoblastoid interferon and acyclovir for treatment of cytomegaloviral pneumonia.
    Shepp DH; Newton BA; Meyers JD
    J Infect Dis; 1984 Nov; 150(5):776-7. PubMed ID: 6092489
    [No Abstract]   [Full Text] [Related]  

  • 11. Prospects for development and potential impact of a vaccine against congenital cytomegalovirus (CMV) infection.
    Schleiss MR
    J Pediatr; 2007 Dec; 151(6):564-70. PubMed ID: 18035130
    [No Abstract]   [Full Text] [Related]  

  • 12. Recombinant leukocyte A interferon for the treatment of serious viral infections after marrow transplant: a phase I study.
    Meyers JD; Day LM; Lum LG; Sullivan KM
    J Infect Dis; 1983 Sep; 148(3):551-6. PubMed ID: 6311915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of cytomegalovirus infection in bone marrow transplant recipients by prophylaxis with an intravenous, hyperimmune cytomegalovirus globulin.
    Condie RM; O'Reilly RJ
    Birth Defects Orig Artic Ser; 1984; 20(1):327-44. PubMed ID: 6329370
    [No Abstract]   [Full Text] [Related]  

  • 14. The challenge of cytomegalovirus infection after bone marrow transplantation: epidemiology, prophylaxis, and therapy.
    Reusser P
    Bone Marrow Transplant; 1996 Nov; 18 Suppl 2():107-9. PubMed ID: 8932809
    [No Abstract]   [Full Text] [Related]  

  • 15. Passive immunization against cytomegalovirus during pregnancy.
    Carbillon L
    N Engl J Med; 2005 Dec; 353(26):2818-20; author reply 2818-20. PubMed ID: 16382549
    [No Abstract]   [Full Text] [Related]  

  • 16. Cytomegalovirus vaccine in renal allograft recipients.
    Marker SC; Simmons RL; Balfour HH
    Transplant Proc; 1981 Mar; 13(1 Pt 1):117-9. PubMed ID: 6267748
    [No Abstract]   [Full Text] [Related]  

  • 17. Human cytomegalovirus glycoprotein B genotypes in immunocompetent, immunocompromised, and congenitally infected Italian populations.
    Arista S; De Grazia S; Giammanco GM; Di Carlo P; Iannitto E
    Arch Virol; 2003 Mar; 148(3):547-54. PubMed ID: 12607105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Commercial methods for the diagnosis of CMV infection after organ or bone marrow transplantation].
    Schvoerer E; Stoll-Keller F
    Ann Biol Clin (Paris); 2002; 60(4):463-7. PubMed ID: 12147450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of cytomegaloviral pneumonia with high-dose acyclovir and human leukocyte interferon.
    Wade JC; McGuffin RW; Springmeyer SC; Newton B; Singer JW; Meyers JD
    J Infect Dis; 1983 Sep; 148(3):557-62. PubMed ID: 6311916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human cytomegalovirus: pathology, diagnosis, treatment.
    Colimon R; Michelson S
    Adv Nephrol Necker Hosp; 1990; 19():333-56. PubMed ID: 2154081
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.